in this issue
Regions :: India/Pakistan
Ranbaxy’s API Business Reports Rise in Sales
5:13 AM MST | November 10, 2011 | Deepti Ramesh
Ranbaxy Laboratories (Gurgaon, India) says that its active pharmaceutical ingredients (API) business reported sales of $35 million in the third quarter of 2011, compared with sales of $23 million in the year-ago quarter. Profits for the API business were not disclosed. The company made 38 Drug Master Filings for APIs during the quarter, Ranbaxy says. Ranbaxy reported a total net loss of $103 million in the third quarter of 2011, compared with a net profit of $66 million in the year-ago quarter. The company’s total sales increased to $443 million in the...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee